LEADER 03598nam  2200709Ia 450 
001 9910459646803321
005 20200520144314.0
010   $a1-4443-4778-0
010   $a1-282-77715-7
010   $a9786612777158
010   $a1-4443-2479-9
035   $a(CKB)2670000000047496
035   $a(EBL)589186
035   $a(OCoLC)671495160
035   $a(SSID)ssj0000423051
035   $a(PQKBManifestationID)12189880
035   $a(PQKBTitleCode)TC0000423051
035   $a(PQKBWorkID)10438910
035   $a(PQKB)11673591
035   $a(MiAaPQ)EBC589186
035   $a(Au-PeEL)EBL589186
035   $a(CaPaEBR)ebr10419247
035   $a(CaONFJC)MIL277715
035   $a(EXLCZ)992670000000047496
100   $a20100325d2010      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aMetabolic risk for cardiovascular disease$b[electronic resource] /$fedited by Robert H. Eckel
210   $aDallas, TX $cAmerican Heart Association ;$aChichester, West Sussex, UK $cWiley-Blackwell$d2010
215   $a1 online resource (261 p.)
225 1 $aAHA clinical series
300   $aDescription based upon print version of record.
311   $a1-4051-8104-4 
320   $aIncludes bibliographical references and index.
327   $aMetabolic Riskfor CardiovascularDisease; Contents; Contributors; Foreword; 1 Insulin action and beta-cell function: role in metabolic regulation; 2 Lipid and lipoprotein metabolism, and risk for cardiovascular disease; 3 Tobacco and risk for cardiovascular disease; 4 Nutrition and risk for cardiovascular disease; 5 Physical activity and cardiovascular health; 6 The obesity epidemic and cardiovascular risk; 7 Insulin resistance, the metabolic syndrome, and cardiovascular risk; 8 Diabetes mellitus and cardiovascular risk; 9 Lipid management and cardiovascular risk reduction
327   $a10 Obesity management and cardiovascular risk reduction11 Diabetes management and cardiovascular risk reduction; 12 A healthy lifestyle and cardiovascular risk reduction; Index; Author Disclosure Table
330   $aThe relationship of metabolic diseases to cardiovascular disease (CVD) is reaching epidemic proportions. This relates mostly to the increasing prevalence of obesity, the metabolic syndrome and type 2 diabetes. This book outlines and addresses the metabolic factors and related diseases that contribute to CVD, including brief introductions to metabolic pathways including lipid and lipoprotein metabolism, macronutrient fuel partitioning, insulin action and body weight regulation. Mechanisms that relate to becoming obese, maintenance of the obese state, the dyslipidemias, and glucose intolerance
410  0$aAHA clinical series.
606   $aCardiovascular system$xDiseases$xRisk factors
606   $aMetabolic syndrome
606   $aObesity$xComplications
606   $aLipids$xMetabolism$xDisorders$xComplications
606   $aDiabetes$xComplications
608   $aElectronic books.
615  0$aCardiovascular system$xDiseases$xRisk factors.
615  0$aMetabolic syndrome.
615  0$aObesity$xComplications.
615  0$aLipids$xMetabolism$xDisorders$xComplications.
615  0$aDiabetes$xComplications.
676   $a616.1/071
701   $aEckel$b Robert H$0984695
712 02$aAmerican Heart Association.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910459646803321
996   $aMetabolic risk for cardiovascular disease$92250147
997   $aUNINA